OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Antibody-Drug Conjugates in Breast Cancer: A Comprehensive Review of How to Selectively Deliver Payloads
Mariana Ribeiro Monteiro, Natália Abou Hala Nunes, Aumilto Junior, et al.
Breast Cancer Targets and Therapy (2024) Vol. Volume 16, pp. 51-70
Open Access | Times Cited: 6
Mariana Ribeiro Monteiro, Natália Abou Hala Nunes, Aumilto Junior, et al.
Breast Cancer Targets and Therapy (2024) Vol. Volume 16, pp. 51-70
Open Access | Times Cited: 6
Showing 6 citing articles:
Antibody-drug conjugates in breast cancer treatment: resistance mechanisms and the role of therapeutic sequencing
Éric Larose, Xinying Hua, Silin Yu, et al.
Cancer Drug Resistance (2025)
Open Access
Éric Larose, Xinying Hua, Silin Yu, et al.
Cancer Drug Resistance (2025)
Open Access
Targeting the tumour cell surface in advanced prostate cancer
Cristina Boixareu, Tarek Taha, Varadha Balaji Venkadakrishnan, et al.
Nature Reviews Urology (2025)
Closed Access
Cristina Boixareu, Tarek Taha, Varadha Balaji Venkadakrishnan, et al.
Nature Reviews Urology (2025)
Closed Access
Role of antibody drug conjugates in the treatment of patients with breast cancer brain metastases
Stacey Pan, Jayant Y. Gadrey, Sarah Sammons, et al.
Therapeutic Advances in Medical Oncology (2024) Vol. 16
Open Access | Times Cited: 1
Stacey Pan, Jayant Y. Gadrey, Sarah Sammons, et al.
Therapeutic Advances in Medical Oncology (2024) Vol. 16
Open Access | Times Cited: 1
Navigating the Future: Advancements in Monoclonal Antibody Nanoparticle Therapy for Cancer
Harshad S. Kapare, Mayuri Bhosale, Ritesh Bhole
Journal of Drug Delivery Science and Technology (2024) Vol. 104, pp. 106495-106495
Closed Access | Times Cited: 1
Harshad S. Kapare, Mayuri Bhosale, Ritesh Bhole
Journal of Drug Delivery Science and Technology (2024) Vol. 104, pp. 106495-106495
Closed Access | Times Cited: 1
Biological mechanisms of resistance to trastuzumab and ways to overcome them: Mod-ern problems of clinical oncology
О. І. Vynnychenko, Roman Moskalenko
Regulatory Mechanisms in Biosystems (2024) Vol. 15, Iss. 2, pp. 345-352
Open Access
О. І. Vynnychenko, Roman Moskalenko
Regulatory Mechanisms in Biosystems (2024) Vol. 15, Iss. 2, pp. 345-352
Open Access
Unfavorable Prognostic Impact of HER2 2+/FISH-Negativity in Older Patients with HER2-Negative and High-Risk Breast Cancer
Hao Wang, Miao Yu, M Chen, et al.
Breast Cancer Targets and Therapy (2024) Vol. Volume 16, pp. 785-793
Open Access
Hao Wang, Miao Yu, M Chen, et al.
Breast Cancer Targets and Therapy (2024) Vol. Volume 16, pp. 785-793
Open Access
